MRK vs TECH · P/E 33, rev $65.01B vs P/E 65, rev $1.22B
Merck & Company Inc (MRK) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MRK and TECH stock pages for the full models.
Not investment advice.